Intensive subsidy necessary on growth potential products.

Dr. Han Byeong-hyeon of the Korea Health Industry Development Institute (KHIDI) recently reported in his paper titled "The present status and its development plans for pharmaceutical industry" that the intensive supports on the growth potential products, the infrastructure buildup for the global market entries and the government policy and system reform plan would be the key factors for the dev...